The FDA has issued an update to the previous alert on the interaction between calcium and ceftriaxone (Rocephin). The original warning was based on reported fatalities involving neonates. The update occurred after Roche (manufacturer of ceftriaxone) conducted two studies using neonatal and adult plasma with varying concentrations of ceftriaxone and calcium. Based on the results, ceftriaxone and calcium-containing products may now be used concomitantly in patients greater than 28 days old.
From the Action News website:Â “The raid began shortly after employees reported for work Wednesday morning. Â Agents with the Defense Criminal Investigations Service rolled in with a rented box truck….DCIS confirms they were looking for records in connection with a specific military contract.” – Huh, we use Siemens Pharmacy Clinical Worksatation as our pharmacy system.